News Outlets Examine Efforts To Develop Coronavirus Treatments, Diagnostics; Debate Over Malaria Drug Off-Label Use Continues

Bloomberg: Malaria Drug Not Showing Promise (4/2).

The Lancet: Developing antibody tests for SARS-CoV-2 (Petherick, 4/4).

POLITICO: No ‘magic pill’: The fight over unproven drugs for coronavirus (Owermohle, 4/2).

PRI: Monopoly on COVID-19 treatment would be ‘dangerously stupid,’ MSF doctor says (4/2).

Reuters: Exclusive: Sanofi can produce millions of doses of potential coronavirus drug — CEO (Blamont/Erman, 4/2).

Washington Times: Hydroxychloroquine rated ‘most effective therapy’ by doctors for coronavirus: Global survey (Richardson, 4/2).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.